Concepedia

Hirohito Yamaguchi

HY

Statistics

Publications

84

Citations

12.3K

H-Index

47

Active since

1986

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

China Medical University

Asia University

Moffitt Cancer Center

University of South Florida

Hirohito Yamaguchi is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, molecular oncology, and life sciences.

ORCID

Publications per year

1986–2024

84

Publications

84

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

Chia‐Wei Li, Seung-Oe Lim, Weiya Xia et al. · Nature Communications · 2016 · 1.1K citations · Full text

, , +17

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

Shiping Jiao, Weiya Xia, Hirohito Yamaguchi et al. · Clinical Cancer Research · 2017 · 975 citations

, , +17

CHOP Is Involved in Endoplasmic Reticulum Stress-induced Apoptosis by Enhancing DR5 Expression in Human Carcinoma Cells

Hirohito Yamaguchi, Hong‐Gang Wang · Journal of Biological Chemistry · 2004 · 834 citations · Full text

, , +17

Deubiquitination and Stabilization of PD-L1 by CSN5

Seung-Oe Lim, Chia‐Wei Li, Weiya Xia et al. · Cancer Cell · 2016 · 767 citations · Full text

, , +3

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

Jer-Yen Yang, Cong S. Zong, Weiya Xia et al. · Nature Cell Biology · 2008 · 699 citations

, , +12

1–5 of 84